Gaydosik et al. identified activation of many tumour-associated signalling pathways that are unique to each tumour: activation of eIF2, eIF4 mTOR signalling, NK-cell signalling, and virus entry via endocytic pathways [11]. This evidence concerns the gene MTOR and neoplasm.